Clin2
NCT06200779Possibly a fitNot yet recruiting

Personalized versus standard treatment for H. pylori infection

Helicobacter Pylori Infection

Part of Digestive system, Infections clinical trials.

This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
160 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older and planning to have an upper endoscopy with a biopsy (a procedure that takes a small tissue sample from your stomach).
  • You cannot have taken antibiotics in the past month.
  • You cannot have taken a proton pump inhibitor (like omeprazole) in the past 2 weeks.
  • You must not have been treated for H. pylori before.
  • You cannot have had stomach surgery to remove part of your stomach, and you must be Portuguese.
  • You must not be pregnant or breastfeeding, and if you are a woman of childbearing age, you must use effective birth control.
  • You cannot have an allergy to amoxicillin (a common antibiotic), serious health conditions, or be on blood thinners.
  • During the endoscopy, you cannot have stomach cancer, bleeding in the stomach, or enlarged veins in the stomach.
  • The biopsy must show that you actually have an H. pylori infection.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07439445Recruiting
Simplified treatment for H. pylori guided by a stool test

This trial tests a simpler two-drug treatment for H. pylori infection, chosen based on a stool test that checks if the bacteria are resistant to clarithromycin. It may help people who have not been treated before avoid unnecessary antibiotics.

Beijing, Beijing Municipality
NCT05332444Recruiting· Phase 4
Check if stomach-bacteria testing improves rescue treatment for H. pylori

This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.

Taipei
NCT07405697Not yet recruiting· Phase 4
Personalized treatment for stubborn H. pylori infection

This study tests a new way to choose antibiotics for H. pylori infection when the usual treatment has failed. By looking at your stool sample, doctors can pick the medicine most likely to work for you.

Shanghai, Shanghai Municipality
NCT07827170Not yet recruiting
Probiotics with standard H. pylori treatment

This study tests whether adding a probiotic (a healthy bacteria supplement) to the standard four-drug treatment for H. pylori infection helps get rid of the bacteria better and with fewer side effects. It may help make your treatment more effective and easier to tolerate.

Hanoi
NCT05926804Recruiting
Screening and treatment for Helicobacter pylori in teens

This trial checks teenagers for a long-lasting H. pylori stomach infection and then treats those who need it. It may help prevent ongoing stomach problems from the infection and compare outcomes between treated and non-treated groups.

Coyhaique
NCT07104318Not yet recruiting· Phase 3
Personalized treatment for H. pylori infection in veterans

This study compares a treatment plan that is customized to the person's genes with the usual standard care for getting rid of H. pylori, a common stomach infection. The goal is to see if the personalized approach works better for veterans.

San Diego, California

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.